Mechanisms of transcellular transport of wheat germ agglutinin-functionalized polymeric nanoparticles in Caco-2 cells.

Transcellular transport is essential for transmucosal and plasma-to-tissue drug delivery by nanoparticles, whereas its fundamental pathways have not been fully clarified. In this study, an in-depth investigation was conducted into the intracellular itinerary and the transcytosis pathway of wheat germ agglutinin-functionalized nanoparticles (WGA-NP) with various polymer architectures in the Caco-2 cell model. GFP-Rabs, Rab4, Rab5, Rab7, Rab11, GTPases served as key regulators of vesicular transport, and their mutants were transfected to Caco-2 cells respectively to determine the cellular itinerary of WGA-NP and the role of Rabs therein. Transcytosis inhibition experiments indicated that transcellular transport of WGA-NP (PEG(3000)-PLA(40000) formulation) happened in a cytoskeleton-dependent manner and majorly by means of clathrin-mediated mechanism. Intracellular transport, especially the endolysosome pathway was found largely contribute to the transcytosis of WGA-NP. WGA-NP with shorter surface PEG length (2000) resulted in higher cellular association and more colocalization with the clathrin-mediated transport pathway, while that with longer surface PEG length (5000) avoided the clathrin-mediated transport pathway but achieved higher transcytosis after 4 h incubation. WGA-NP with PLGA as the core materials obtained elevated lysosome escape and enhanced transcytosis after 2 h incubation. These findings provided important evidence for the role of polymer architectures in modulating cellular transport of functionalized nanocarriers, and would be helpful in improving carrier design to enhance drug delivery.

[1]  Cui Tang,et al.  Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. , 2010, Biomaterials.

[2]  D. Begley,et al.  Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[3]  P. van der Sluijs,et al.  rab4 Regulates Transport to the Apical Plasma Membrane in Madin-Darby Canine Kidney Cells* , 2002, The Journal of Biological Chemistry.

[4]  W. Lu,et al.  Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration. , 2006, Cancer research.

[5]  M. Holl,et al.  The mechanism of polyplex internalization into cells: testing the GM1/caveolin-1 lipid raft mediated endocytosis pathway. , 2010, Molecular pharmaceutics.

[6]  Xin-guo Jiang,et al.  Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery. , 2011, Biomaterials.

[7]  Xin-guo Jiang,et al.  Quantum dots for tracking cellular transport of lectin-functionalized nanoparticles. , 2008, Biochemical and biophysical research communications.

[8]  Samuel A Wickline,et al.  Exploiting lipid raft transport with membrane targeted nanoparticles: a strategy for cytosolic drug delivery. , 2008, Biomaterials.

[9]  W. Saltzman,et al.  The uptake and intracellular fate of PLGA nanoparticles in epithelial cells. , 2009, Biomaterials.

[10]  C. Tsilfidis,et al.  PEG-PLA microparticles for encapsulation and delivery of Tat-EGFP to retinal cells. , 2010, Biomaterials.

[11]  Yi Han,et al.  Predicting Caco-2 Cell Permeation Coefficients of Organic Molecules Using Membrane-Interaction QSAR Analysis , 2002, J. Chem. Inf. Comput. Sci..

[12]  Michael Wirth,et al.  The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery. , 2004, Advanced drug delivery reviews.

[13]  Xin-guo Jiang,et al.  The association of autophagy with polyethylenimine-induced cytotoxicity in nephritic and hepatic cell lines. , 2011, Biomaterials.

[14]  P. Opanasopit,et al.  In vitro Permeability Enhancement in Intestinal Epithelial Cells (Caco-2) Monolayer of Water Soluble Quaternary Ammonium Chitosan Derivatives , 2010, AAPS PharmSciTech.

[15]  H. Takeuchi,et al.  In vitro and in vivo evaluation of WGA-carbopol modified liposomes as carriers for oral peptide delivery. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[16]  A. Jones,et al.  Establishment of subcellular fractionation techniques to monitor the intracellular fate of polymer therapeutics II. Identification of endosomal and lysosomal compartments in HepG2 cells combining single-step subcellular fractionation with fluorescent imaging , 2007, Journal of drug targeting.

[17]  I. Alves,et al.  Cell biology meets biophysics to unveil the different mechanisms of penetratin internalization in cells. , 2010, Biochimica et biophysica acta.

[18]  W. Shen,et al.  Accumulation of transferrin in Caco-2 cells: a possible mechanism of intestinal transferrin absorption. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[19]  G. Berger,et al.  Glycoconjugate Expression in Normal Human Inferior Turbinate Mucosa: A Lectin Histochemical Study , 2005, American journal of rhinology.

[20]  V. Torchilin,et al.  Biodegradable long-circulating polymeric nanospheres. , 1994, Science.

[21]  R. Narain,et al.  The effect of polymer architecture, composition, and molecular weight on the properties of glycopolymer-based non-viral gene delivery systems. , 2011, Biomaterials.

[22]  Tilen Koklic,et al.  Impact of membrane properties on uptake and transcytosis of colloidal nanocarriers across an epithelial cell barrier model. , 2010, Journal of pharmaceutical sciences.

[23]  Zhiqiang Yan,et al.  Odorranalectin-conjugated nanoparticles: preparation, brain delivery and pharmacodynamic study on Parkinson's disease following intranasal administration. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[24]  Eric Pridgen,et al.  Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.

[25]  Jayanth Panyam,et al.  Rapid endo‐lysosomal escape of poly(DL‐lactide‐coglycolide) nanoparticles: implications for drug and gene delivery , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  J. Benoit,et al.  The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability. , 2010, Biomaterials.

[27]  Kai Simons,et al.  The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway , 1992, Cell.

[28]  Leaf Huang,et al.  Pharmacokinetics and biodistribution of nanoparticles. , 2008, Molecular pharmaceutics.

[29]  Tejal A Desai,et al.  PEGylated silicon nanowire coated silica microparticles for drug delivery across intestinal epithelium. , 2012, Biomaterials.

[30]  J. Benoit,et al.  Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[31]  Wei Lu,et al.  Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration. , 2006, Biomaterials.

[32]  Xin-guo Jiang,et al.  Effect of wheat germ agglutinin density on cellular uptake and toxicity of wheat germ agglutinin conjugated PEG-PLA nanoparticles in Calu-3 cells. , 2011, International journal of pharmaceutics.

[33]  J. Benoit,et al.  The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting. , 2010, Nanomedicine.

[34]  Marino Zerial,et al.  Rab proteins as membrane organizers , 2001, Nature Reviews Molecular Cell Biology.

[35]  S. Sant,et al.  Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles. , 2008, Journal of biomedical materials research. Part A.

[36]  S. Hamm-Alvarez,et al.  Tyrphostin A8 stimulates a novel trafficking pathway of apically endocytosed transferrin through Rab11-enriched compartments in Caco-2 cells. , 2008, American journal of physiology. Cell physiology.

[37]  J. Kopeček,et al.  Endocytic uptake of a large array of HPMA copolymers: Elucidation into the dependence on the physicochemical characteristics. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[38]  D. Balding,et al.  HLA Sequence Polymorphism and the Origin of Humans , 2006 .

[39]  A. Wandinger-Ness,et al.  Rab proteins and endocytic trafficking: potential targets for therapeutic intervention. , 2003, Advanced drug delivery reviews.

[40]  Lan Ma,et al.  Phosphorylation state of mu-opioid receptor determines the alternative recycling of receptor via Rab4 or Rab11 pathway. , 2008, Molecular endocrinology.

[41]  B. Deurs,et al.  Rab7: a key to lysosome biogenesis. , 2000, Molecular biology of the cell.

[42]  Huibi Xu,et al.  Role of cellular uptake in the reversal of multidrug resistance by PEG-b-PLA polymeric micelles. , 2011, Biomaterials.

[43]  R. Langer,et al.  Drug delivery and targeting. , 1998, Nature.

[44]  Michael J Rust,et al.  Ligands for Clathrin-Mediated Endocytosis Are Differentially Sorted into Distinct Populations of Early Endosomes , 2006, Cell.

[45]  Wei Chen,et al.  Rab11 is required for trans-golgi network-to-plasma membrane transport and a preferential target for GDP dissociation inhibitor. , 1998, Molecular biology of the cell.

[46]  Surya Singh Nanomedicine-nanoscale drugs and delivery systems. , 2010, Journal of nanoscience and nanotechnology.

[47]  H. McBride,et al.  The Rab5 effector EEA1 is a core component of endosome docking , 1999, Nature.

[48]  V. Protasenko,et al.  Experimental determination of the absorption cross-section and molar extinction coefficient of CdSe and CdTe nanowires. , 2006, The journal of physical chemistry. B.

[49]  M. Wirth,et al.  Lectin-mediated drug delivery: binding and uptake of BSA-WGA conjugates using the Caco-2 model. , 2002, International journal of pharmaceutics.

[50]  Brian Storrie,et al.  Capacity of the Golgi apparatus for cargo transport prior to complete assembly. , 2006, Molecular biology of the cell.

[51]  L. Lim,et al.  Mechanistic study of the uptake of wheat germ agglutinin-conjugated PLGA nanoparticles by A549 cells. , 2004, Journal of pharmaceutical sciences.

[52]  A. Abulrob,et al.  Integrated platform for brain imaging and drug delivery across the blood-brain barrier. , 2011, Methods in molecular biology.

[53]  M. Barbieri,et al.  Role of Rab5 in insulin receptor-mediated endocytosis and signaling. , 2006, Archives of biochemistry and biophysics.

[54]  Chunxiao Wang,et al.  Wheat germ agglutinin-conjugated PLGA nanoparticles for enhanced intracellular delivery of paclitaxel to colon cancer cells. , 2010, International journal of pharmaceutics.

[55]  Xinguo Jiang,et al.  Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[56]  M. Zegers,et al.  Actin filaments and microtubules are involved in different membrane traffic pathways that transport sphingolipids to the apical surface of polarized HepG2 cells. , 1998, Molecular biology of the cell.